It’s now one week to go until the Association for Continence Advice (ACA) Annual Conference and Exhibition! Taking place on the 22nd and 23rd May, this year’s conference will be taking place at the prestigious Waterfront Belfast in Northern Ireland.
Making a choice of catheterisation gel
The ACA Annual Conference and Exhibition this year is being kick-started with a very interesting presentation, delivered by Cath Williams – ACA Executive Committee Member and Locality Leader at North Somerset Community Partnership. Cath’s presentation is titled ‘Making a choice of catheterisation gel – reducing risk and enhancing patient-centred care.’
This presentation will be taking place at 09:30 on Monday 22nd May in the main session room. In her talk, Cath will be touching on the benefits of using a catheterisation gel which contains Lidocaine 2% without Chlorhexidine. This is in response to the increasing number of sensitivity reactions which are occurring on exposure to Chlorhexidine*.
OptiLube Active CHG Free
Optimum Medical will be exhibiting on stand 53 at the ACA. We’ll be showcasing our catheterisation jelly range, including our newest addition – OptiLube Active CHG Free. OptiLube Active CHG Free is the ONLY catheterisation gel currently available in the UK which contains Lidocaine 2% without Chlorhexidine. Evidence demonstrates that repeated exposure to Chlorhexidine can increase the risk of sensitisation.* This makes OptiLube Active CHG Free the ideal gel to use on patients with a known sensitivity to this active ingredient.
The range also includes OptiLube Active (with 2% Lidocaine and 0.25% Chlorhexidine Gluconate) and OptiLube (without active ingredients). By providing a range of catheterisation gels, we give clinicians a choice of which gel to use based on individual patient assessment, leading to improved patient outcomes.
Want to know more about our catheterisation jelly range? Clinicians attending the ACA can visit Optimum Medical on stand 53 and we’ll gladly talk you through the range. Alternatively, for more information you can email [email protected], call 0113 263 3849 or click here to view the catheterisation jelly page on our website.
* Marinho S., Oliver P., Hughes D (2013). Chlorhexidine Allergy Policy. Screening and management of patients with Chlorhexidine allergy. University Hospital of South Manchester NHS Foundation Trust.